Randomised clinical trial: minesapride vs placebo for irritable bowel syndrome with predominant constipation.

"Declaration of personal interests : Tatsuto Hamatani, Yosuke Nakada, Hiroshi Inada, and Kiyoyasu Kazumori are employees of Sumitomo Dainippon Pharma Co., Ltd. Shin Fukudo and Hiroto Miwa served as coordinating investigators and received consultation fees from Sumitomo Dainippon Pharma Co., Ltd. Declaration of funding interests : This study was funded by Sumitomo Dainippon Pharma Co., Ltd."

"Funding information"

"This study was conducted in accordance with the ethical principles that have their origin in the Declaration of Helsinki, and in compliance with the protocol, ICH‐good clinical practice, and related notifications. The investigator ensured that potential subjects were given full and adequate verbal and written information regarding the nature, purpose, and possible risks and benefits of the study. The investigator obtained a signed informed consent form from all subjects before any study procedures were performed. This study was registered with Japan Pharmaceutical Information Center, number Japic CTI‐163459. All authors had access to the study data and reviewed and approved the final manuscript."